Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Zambia Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The somewhat rebounded copper prices seen since the beginning of this year may prevent the deepening of the economic crisis in Zambia after the prices depreciated in 2014. This may prompt the government to stick with its commitm...
May 2015 $ 1295
Sweden Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Private healthcare providers are to face an increasingly challenging business environment in Sweden. In October 2014, the newly elected government reached an agreement on initiatives aimed at imposing further restrictions on pri...
May 2015 $ 1295
Jordan Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Jordan's pharmaceutical pricing legislation is likely to result in further medicine price cuts in 2015. Patent expiries and referencing prices to Saudi Arabia will inevitably lead to further reductions, particularly given the on...
May 2015 $ 1295
Cameroon Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Headline Expenditure Projections ? Pharmaceuticals: XAF170.33bn (USD348mn) in 2014 to XAF187.60bn (USD315mn) in 2015; +10.1% in local currency terms and -9.6% in US dollar terms. Forecast revised downwards from last quarte...
May 2015 $ 1295
Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars
By Access China Management Consulting Ltd
Summary China has an indispensable biosimilar market for overseas and multinational pharmaceutical companies. Historical data shows 40 per cent of China's $1.5bn recombinant biologic product sales come from biosimilars, wh...
May 2015 $ 750
Tanzania Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The introduction of compulsory health insurance in Tanzania will increase uptake of the scheme among some sectors of the population. Despite the impressive employment rate, contributions from those employed in the informal and a...
May 2015 $ 1295
Poland Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The National Health Fund and the Agency for Health Technology Assessment will continue to impede the reimbursement of innovative drugs in Poland over the short term, given their current focus on budgetary restraint. Over the lon...
May 2015 $ 1295
Pakistan Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Medicine sales in Pakistan will continue to grow significantly from a low base. Underpinning this trajectory includes a reform in the country's pricing environment that will see scope for an increase in pharmaceutical prices. Th...
May 2015 $ 1295
Japan Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The Japanese pharmaceutical market will become increasingly challenging for multinational drugmakers. This comes as the use of generic drugs has begun to gain momentum, creating a more competitive environment for innovative medi...
May 2015 $ 1295
Hungary Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Hungary's attractiveness to multinational drugmakers will be impeded by onerous regulatory burden, pricing pressures and punitive taxes on pharmaceutical companies. Combined, these factors will impede growth in pharmaceutical sa...
May 2015 $ 1295
Hong Kong Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Financial constrains coupled with the lack of healthcare facilities and medical professional in the public sector meant that the private healthcare sector will play an increasingly important role in Hong Kong. This shift also me...
May 2015 $ 1295
Colombia Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The government's push for improvement to the Colombian healthcare sector, combined with the country's growing burden of chronic conditions and reliance on imported drugs will keep the healthcare and pharmaceutical markets on pos...
May 2015 $ 1295
Austria Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. Nevertheless, our pharmaceutical and healthcare expenditure growth expectations ...
May 2015 $ 1295
Thailand Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Competitively priced medical services, government support of the healthcare sector and Thailand's position as a popular holiday destination will continue to boost the growth of the country's medical tourism industry. This will p...
May 2015 $ 1295
South Korea Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The South Korean government will continue to enforce price pressures on pharmaceuticals as a means to contain the escalating healthcare costs brought on by the country's ageing population. This is particularly as other avenues -...
May 2015 $ 1295
Slovenia Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Positive economic developments in the eurozone and increasing competitiveness due to euro depreciation should boost demand for Slovenian pharmaceutical exports. It is also likely that economic pickup in Slovenia will push demand...
May 2015 $ 1295
Netherlands Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: The healthcare market in the Netherlands will continue to offer considerable commercial opportunities. As a part of the Health Insurance Act, implemented in 2006, private insurance for curative care and supplemental benefits is ...
May 2015 $ 1295
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Implementation of Côte d'Ivoire's universal healthcare scheme will drive demand for prescription medicines, with generic drugmakers the likely beneficiaries. The government will increase its share of the total healthcare market ...
May 2015 $ 1295
Central America Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Favourable tax incentives, continued demand for both generic and patented medicines, and regional anti-counterfiet measures solidify Central America's revenue generating opportunities for multinational pharmaceutical companies i...
May 2015 $ 1295
Argentina Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Argentina's pharmaceuticals and healthcare sector is expected to experience improved growth rates through the next decade, standing slightly behind growth patterns in the other large markets in Latin America. Combined with expec...
May 2015 $ 1295
Angola Pharmaceuticals and Healthcare Report Q3 2015
By Business Monitor International
BMI View: Angola's pharmaceutical market is held back by weak regulatory framework and lack of intellectual property legislation which create a challenging environment for innovative drugmakers. The fall in the price of oil will have a he...
May 2015 $ 1295
Global Hemophilia Market Report: 2015 Edition
By Koncept Analytics
Hemophilia is an inherited or acquired bleeding disorder that prevents blood from clotting. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. People with hemophilia do not ...
May 2015 $ 800
Ebola Partnering 2010-2015
By Current Partnering
Delivery of this report will take 1-3 days after purchase. The Ebola Partnering 2010-2015 report provides understanding and access to the ebola partnering deals and agreements entered into by the worlds leading healthcare companies....
May 2015 $ 795
Clostridium difficile Partnering 2010-2015
By Current Partnering
Delivery of this report will take 1-3 days after purchase. The Clostridium difficile Partnering 2010-2015 report provides understanding and access to the Clostridium difficile partnering deals and agreements entered into by the worlds le...
May 2015 $ 795
Influenza Partnering 2010-2015
By Current Partnering
Delivery of this report will take 1-3 days after purchase. The Influenza Partnering 2010-2015 report provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare compani...
May 2015 $ 995
Live Chat
Live Chat by Comm100